Mannkind (MNKD) Accumulated Depreciation & Amortization (2010 - 2026)
Mannkind (MNKD) reported Accumulated Depreciation & Amortization of $115.8 million for Q1 2026, up 6.55% year-over-year from $108.7 million in Q1 2025, and up 1.65% on a QoQ basis from $113.9 million in Q4 2025.
Mannkind (MNKD) has 17 years of Accumulated Depreciation & Amortization data on file, last reported at $115.8 million in Q1 2026.
- Quarterly Accumulated Depreciation & Amortization rose 6.55% year-over-year to $115.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $115.8 million (up 6.55% YoY) and the FY2025 annual result came in at $113.9 million, up 6.78% from the prior year.
- Accumulated Depreciation & Amortization rose to $115.8 million in Q1 2026 per MNKD's latest filing, from $113.9 million in the prior quarter.
- Across five years, Accumulated Depreciation & Amortization topped out at $115.8 million in Q1 2026 and bottomed at $97.9 million in Q1 2022.
- The 5-year median for Accumulated Depreciation & Amortization is $102.8 million (2024), against an average of $104.7 million.
- The widest annual swing landed in 2022, when Accumulated Depreciation & Amortization rose 0.92%; it then rose 6.78% in 2025.
- Tracing MNKD's Accumulated Depreciation & Amortization over 5 years: stood at $98.6 million in 2022, then climbed by 3.02% to $101.5 million in 2023, then rose by 5.06% to $106.7 million in 2024, then advanced by 6.78% to $113.9 million in 2025, then increased by 1.65% to $115.8 million in 2026.
- Per Business Quant, the three latest MNKD Accumulated Depreciation & Amortization figures stand at $115.8 million (Q1 2026), $113.9 million (Q4 2025), and $112.7 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Mannkind | 1.09 Bn | 956.66 Mn | 82.66 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 115.79 Mn |
| Mar 31, 2026 | 115.79 Mn |
| Dec 31, 2025 | 113.91 Mn |
| Dec 31, 2025 | 113.91 Mn |
| Sep 30, 2025 | 112.73 Mn |
| Sep 30, 2025 | 112.73 Mn |
| Jun 30, 2025 | 110.72 Mn |
| Jun 30, 2025 | 110.72 Mn |
| Mar 31, 2025 | 108.68 Mn |
| Mar 31, 2025 | 108.68 Mn |
| Dec 31, 2024 | 106.68 Mn |
| Dec 31, 2024 | 106.68 Mn |
| Sep 30, 2024 | 106.63 Mn |
| Sep 30, 2024 | 106.63 Mn |
| Jun 30, 2024 | 104.54 Mn |
| Jun 30, 2024 | 104.54 Mn |
| Mar 31, 2024 | 102.83 Mn |
| Mar 31, 2024 | 102.83 Mn |
| Dec 31, 2023 | 101.54 Mn |
| Dec 31, 2023 | 101.54 Mn |
| Sep 30, 2023 | 101.29 Mn |
| Sep 30, 2023 | 101.29 Mn |
| Jun 30, 2023 | 100.22 Mn |
| Jun 30, 2023 | 100.22 Mn |
| Mar 31, 2023 | 99.55 Mn |
| Mar 31, 2023 | 99.55 Mn |
| Dec 31, 2022 | 98.56 Mn |
| Dec 31, 2022 | 98.56 Mn |
| Sep 30, 2022 | 99.12 Mn |
| Sep 30, 2022 | 99.12 Mn |
| Jun 30, 2022 | 98.56 Mn |
| Jun 30, 2022 | 98.56 Mn |
| Mar 31, 2022 | 97.91 Mn |
| Mar 31, 2022 | 97.91 Mn |
| Dec 31, 2021 | 97.66 Mn |
| Dec 31, 2021 | 97.66 Mn |
| Sep 30, 2021 | 97.67 Mn |
| Sep 30, 2021 | 97.67 Mn |
| Jun 30, 2021 | 97.32 Mn |
| Jun 30, 2021 | 97.32 Mn |
| Mar 31, 2021 | 96.84 Mn |
| Mar 31, 2021 | 96.84 Mn |
| Dec 31, 2020 | 96.82 Mn |
| Dec 31, 2020 | 96.82 Mn |
| Sep 30, 2020 | 96.62 Mn |
| Sep 30, 2020 | 96.62 Mn |
| Jun 30, 2020 | 96.17 Mn |
| Jun 30, 2020 | 96.17 Mn |
| Mar 31, 2020 | 95.77 Mn |
| Mar 31, 2020 | 95.77 Mn |
| Dec 31, 2019 | 95.36 Mn |
| Dec 31, 2019 | 95.36 Mn |
| Sep 30, 2019 | 101.63 Mn |
| Sep 30, 2019 | 101.63 Mn |
| Jun 30, 2019 | 101.24 Mn |
| Jun 30, 2019 | 101.24 Mn |
| Mar 31, 2019 | 100.87 Mn |
| Mar 31, 2019 | 100.87 Mn |
| Dec 31, 2018 | 100.50 Mn |
| Dec 31, 2018 | 100.50 Mn |
| Sep 30, 2018 | 101.73 Mn |
| Sep 30, 2018 | 101.73 Mn |
| Jun 30, 2018 | 101.39 Mn |
| Jun 30, 2018 | 101.39 Mn |
| Mar 31, 2018 | 100.94 Mn |
| Mar 31, 2018 | 100.94 Mn |
| Dec 31, 2017 | 1.80 Mn |
| Dec 31, 2017 | 1.80 Mn |
| Sep 30, 2017 | 100.70 Mn |
| Sep 30, 2017 | 100.70 Mn |
| Jun 30, 2017 | 100.47 Mn |
| Jun 30, 2017 | 100.47 Mn |
| Mar 31, 2017 | 400,000.00 |
| Mar 31, 2017 | 400,000.00 |
| Dec 31, 2016 | 2.40 Mn |
| Dec 31, 2016 | 2.40 Mn |
| Sep 30, 2016 | 120.62 Mn |
| Sep 30, 2016 | 120.62 Mn |
| Jun 30, 2016 | 1.18 Mn |
| Jun 30, 2016 | 1.18 Mn |
| Mar 31, 2016 | 600,000.00 |
| Mar 31, 2016 | 600,000.00 |
| Dec 31, 2015 | 11.00 Mn |
| Dec 31, 2015 | 11.00 Mn |
| Sep 30, 2015 | 8.28 Mn |
| Sep 30, 2015 | 8.28 Mn |
| Jun 30, 2015 | 2.74 Mn |
| Jun 30, 2015 | 2.74 Mn |
| Mar 31, 2015 | 2.30 Mn |
| Mar 31, 2015 | 2.30 Mn |
| Dec 31, 2014 | 9.80 Mn |
| Dec 31, 2014 | 9.80 Mn |
| Sep 30, 2014 | 4.97 Mn |
| Sep 30, 2014 | 4.97 Mn |
| Jun 30, 2014 | 2.45 Mn |
| Jun 30, 2014 | 2.45 Mn |
| Mar 31, 2014 | 2.50 Mn |
| Mar 31, 2014 | 2.50 Mn |
| Dec 31, 2013 | 11.50 Mn |
| Dec 31, 2013 | 11.50 Mn |
| Sep 30, 2013 | 8.82 Mn |
| Sep 30, 2013 | 8.82 Mn |
| Jun 30, 2013 | 2.96 Mn |
| Jun 30, 2013 | 2.96 Mn |
| Mar 31, 2013 | 2.99 Mn |
| Mar 31, 2013 | 2.99 Mn |
| Dec 31, 2012 | 13.00 Mn |
| Dec 31, 2012 | 13.00 Mn |
| Sep 30, 2012 | 9.90 Mn |
| Sep 30, 2012 | 9.90 Mn |
| Jun 30, 2012 | 3.30 Mn |
| Jun 30, 2012 | 3.30 Mn |
| Mar 31, 2012 | 3.36 Mn |
| Mar 31, 2012 | 3.36 Mn |
| Dec 31, 2011 | 14.60 Mn |
| Dec 31, 2011 | 14.60 Mn |
| Sep 30, 2011 | 3.75 Mn |
| Sep 30, 2011 | 3.75 Mn |
| Jun 30, 2011 | 3.58 Mn |
| Jun 30, 2011 | 3.58 Mn |
| Dec 31, 2010 | 16.50 Mn |
| Dec 31, 2010 | 16.50 Mn |